IFNB1 and neoplasm: As modifications to optimize for systemic therapy, VSV was engineered to encode interferon-beta (IFNβ) to enhance tumor specificity by activating innate immune responses in normal cells, and the sodium iodide symporter (NIS) to allow noninvasive imaging of virus biodistribution [62].